PMID- 34299302 OWN - NLM STAT- MEDLINE DCOM- 20210806 LR - 20210806 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 22 IP - 14 DP - 2021 Jul 19 TI - Short Chain Fatty Acid Acetate Increases TNFalpha-Induced MCP-1 Production in Monocytic Cells via ACSL1/MAPK/NF-kappaB Axis. LID - 10.3390/ijms22147683 [doi] LID - 7683 AB - Short-chain fatty acid (SCFA) acetate, a byproduct of dietary fiber metabolism by gut bacteria, has multiple immunomodulatory functions. The anti-inflammatory role of acetate is well documented; however, its effect on monocyte chemoattractant protein-1 (MCP-1) production is unknown. Similarly, the comparative effect of SCFA on MCP-1 expression in monocytes and macrophages remains unclear. We investigated whether acetate modulates TNFalpha-mediated MCP-1/CCL2 production in monocytes/macrophages and, if so, by which mechanism(s). Monocytic cells were exposed to acetate with/without TNFalpha for 24 h, and MCP-1 expression was measured. Monocytes treated with acetate in combination with TNFalpha resulted in significantly greater MCP-1 production compared to TNFalpha treatment alone, indicating a synergistic effect. On the contrary, treatment with acetate in combination with TNFalpha suppressed MCP-1 production in macrophages. The synergistic upregulation of MCP-1 was mediated through the activation of long-chain fatty acyl-CoA synthetase 1 (ACSL1). However, the inhibition of other bioactive lipid enzymes [carnitine palmitoyltransferase I (CPT I) or serine palmitoyltransferase (SPT)] did not affect this synergy. Moreover, MCP-1 expression was significantly reduced by the inhibition of p38 MAPK, ERK1/2, and NF-kappaB signaling. The inhibition of ACSL1 attenuated the acetate/TNFalpha-mediated phosphorylation of p38 MAPK, ERK1/2, and NF-kappaB. Increased NF-kappaB/AP-1 activity, resulting from acetate/TNFalpha co-stimulation, was decreased by ACSL1 inhibition. In conclusion, this study demonstrates the proinflammatory effects of acetate on TNF-alpha-mediated MCP-1 production via the ACSL1/MAPK/NF-kappaB axis in monocytic cells, while a paradoxical effect was observed in THP-1-derived macrophages. FAU - Al-Roub, Areej AU - Al-Roub A AD - Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait. FAU - Akhter, Nadeem AU - Akhter N AD - Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait. FAU - Al-Sayyar, Amnah AU - Al-Sayyar A AD - Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait. FAU - Wilson, Ajit AU - Wilson A AD - Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait. FAU - Thomas, Reeby AU - Thomas R AD - Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait. FAU - Kochumon, Shihab AU - Kochumon S AD - Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait. FAU - Al-Rashed, Fatema AU - Al-Rashed F AUID- ORCID: 0000-0002-5825-7701 AD - Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait. FAU - Al-Mulla, Fahd AU - Al-Mulla F AUID- ORCID: 0000-0001-5409-3829 AD - Genetics & Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait. FAU - Sindhu, Sardar AU - Sindhu S AUID- ORCID: 0000-0001-9936-1575 AD - Animal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait. FAU - Ahmad, Rasheed AU - Ahmad R AUID- ORCID: 0000-0001-5746-0743 AD - Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait. LA - eng GR - RA-AML-2014-016 and RA AH 2016-007./Kuwait Foundation for the Advancement of Sciences/ PT - Journal Article DEP - 20210719 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Acetates) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Enzyme Inhibitors) RN - 0 (Fatty Acids, Volatile) RN - 0 (NF-kappa B) RN - 0 (RNA, Messenger) RN - 0 (TNF protein, human) RN - 0 (Triazenes) RN - 0 (Tumor Necrosis Factor-alpha) RN - 6M6D4602I5 (triacsin C) RN - EC 6.2.1.- (Coenzyme A Ligases) RN - EC 6.2.1.3 (ACSL1 protein, human) SB - IM MH - Acetates/administration & dosage/*pharmacology MH - Chemokine CCL2/*biosynthesis/genetics MH - Coenzyme A Ligases/antagonists & inhibitors/metabolism MH - Drug Synergism MH - Enzyme Inhibitors/pharmacology MH - Fatty Acids, Volatile/administration & dosage/*pharmacology MH - Humans MH - MAP Kinase Signaling System MH - Models, Biological MH - Monocytes/*drug effects/immunology/*metabolism MH - NF-kappa B/metabolism MH - Obesity/etiology/metabolism MH - Phosphorylation MH - RNA, Messenger/genetics/metabolism MH - THP-1 Cells MH - Triazenes/pharmacology MH - Tumor Necrosis Factor-alpha/administration & dosage/pharmacology PMC - PMC8304091 OTO - NOTNLM OT - AP-1 OT - MCP-1 OT - NF-kappaB OT - THP-1 monocytic cells OT - TNFalpha OT - acetate OT - short-chain fatty acids COIS- The authors declare no conflict of interest. EDAT- 2021/07/25 06:00 MHDA- 2021/08/07 06:00 PMCR- 2021/07/19 CRDT- 2021/07/24 01:03 PHST- 2021/06/16 00:00 [received] PHST- 2021/07/06 00:00 [revised] PHST- 2021/07/09 00:00 [accepted] PHST- 2021/07/24 01:03 [entrez] PHST- 2021/07/25 06:00 [pubmed] PHST- 2021/08/07 06:00 [medline] PHST- 2021/07/19 00:00 [pmc-release] AID - ijms22147683 [pii] AID - ijms-22-07683 [pii] AID - 10.3390/ijms22147683 [doi] PST - epublish SO - Int J Mol Sci. 2021 Jul 19;22(14):7683. doi: 10.3390/ijms22147683.